China’s Blue Sail Medical Co., Ltd. (SHE: 002382) has announced strategic cooperation agreements with the local government of Weifang, Shandong province, as well as Linqu county, also within Weifang. Under this partnership, the Weifang government plans to invest in Blue Sail, facilitating the introduction of various medical and healthcare-related projects to the city. No financial terms or further details have been made public.- Flcube.com
Recent news:
-
Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA -
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China -
Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment -
CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan -
Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
